HFA Icon

Jennifer Wallace: It Ain’t What You Don’t Know That Gets You Into Trouble

HFA Padded
Jacob Wolinsky
Published on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

Jennifer Wallace's notes from the 2019 Value Invest New York Conference. Jennifer is a founding partner of Summit Street Capital Management, LLC and serves as the firm’s Chief Investment Officer and Portfolio Manager.

Q3 2019 hedge fund letters, conferences and more

orphan drug
katicaj / Pixabay

Jennifer Wallace: It Ain't What You Don't Know That Gets You Into Trouble

United Therapeutics Corporation (NASDAQ:UTHR)

  • 21% cash on cash yield
  • stock down 50%
  • 50% margin
  • 100% upside

Pulmonary Arterial Hypertension PAH

  • pure play orphan drug
  • blood vessels in lung
  • 100k die b/c of no lung transplant
  • 50% of rev cliff in 2018
  • false pattern recognition because cliff is being delayed
  • thesis around how generic threat is overplayed
  • $13 net...

    Login required to continue reading.

    Setup a free account to get access to this article (no credit card required).

    View Full Article
    Already a member? Log in here
HFA Padded

Jacob Wolinsky is the ex-Founder of Valuewalk.com (founded 2011, sold 2023). He is founder of HedgeFundAlpha (formerly ValueWalk Premium), a hedge fund focused intelligence service for institutional investors. Prior to founding Valuewalk, Jacob worked as an equity analyst covering small caps, a micro-cap analyst, doing member development a large hedge fund community and freelance financial writing. Jacob lives with his wife and five kids in Passaic NJ. - Email: jacob(at)hedgefundalpha.com. For confidential inquires email me for my Signal id. Other methods of secure communication are also available. FD: I almost exclusively avoid the purchase of equities to avoid conflict of interest and any insider information. I only purchase broad-based ETFs and mutual funds. I will disclsoe if I have a stake in any company, but in general avoid